Neuroplast

Neuroplast is a clinical-stage biotech developing the Neuro-Cells® stem cell product.

Biotechnology

Explore the company ↓Explore its lists ↓

Headquarters: Geleen, Limburg, NetherlandsSource: RevenueBaseRetrieved October 13, 2026
Employee range: 11 to 50Source: RevenueBaseRetrieved October 13, 2026
Founded: 2014Source: RevenueBaseRetrieved October 13, 2026
Published list appearances: 1 supported appearance ↗Source: RevenueBase lists

The company at a glance

What does Neuroplast do?

The company identifies spinal cord injury, ALS and dementia as examples of neurodegenerative diseases. Neuroplast holds European Orphan Disease Designations for spinal cord injury and frontotemporal dementia.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

What the business offers

Services & capabilities.

Stem cell product development

Neuro-Cells® is produced from patients’ own stem cells through an eight-hour patented process and reinjected at the injury site.

Source: LinkedIn company description · Retrieved October 13, 2026

Explore the business in context

Company lists.

Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.

#13OF 17

Netherlands

Cell therapy clinical research organizations

Snapshot: October 8, 2026

↗

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEW

Open the published source list.

Neuroplast

#13 Cell therapy clinical research organizations

Snapshot: October 8, 2026

Display size

Download SVG

Copy this code into your website

<a href="https://revenuebase.ai/companies/cell-therapy-clinical-research-organizations/netherlands" target="_blank" rel="nofollow noopener">
  <img src="https://revenuebase.ai/companies/profiles/neuroplast/recognition-companies-cell-therapy-clinical-research-organizations-netherlands-20261009-9b98b334b9e90dc18ac0ec40ea147ae5cd6bcd47dc4cfd3707cdc13e600208f9.svg" alt="Neuroplast listed #13 on Cell therapy clinical research organizations, October 8, 2026" width="220" height="319" style="max-width:100%;height:auto;" />
</a>

View live list ↗

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated October 8, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Request an update ↗

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →